lactic acid has been researched along with sildenafil citrate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Abisheganaden, J; Chan, CL; Chia, SY; Gan, R; Kao, SL; Khoo, JJ; Lim, CC; Sitoh, YY; Tan, AW | 1 |
Colahan, PT; Jackson, CA; Jones, JH; Rice, B; Szabo, N | 1 |
Beck-Broichsitter, M; Gessler, T; Kissel, T; Kleimann, P; Schmehl, T; Seeger, W | 1 |
Beck-Broichsitter, M; Gessler, T; Kissel, T; Schmehl, T; Schweiger, C; Seeger, W | 1 |
Park, K | 1 |
Ahsan, F; McMurtry, IF; Nozik-Grayck, E; Patel, B; Rashid, J; Stenmark, KR | 1 |
Bai, L; Liu, J; Wang, L; Wu, Q; Zhang, H | 1 |
1 trial(s) available for lactic acid and sildenafil citrate
Article | Year |
---|---|
The effect of sildenafil citrate administration on selected physiological parameters of exercising Thoroughbred horses.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Female; Heart Rate; Horses; Lactic Acid; Male; Phosphodiesterase 5 Inhibitors; Physical Conditioning, Animal; Physical Endurance; Piperazines; Pulmonary Gas Exchange; Purines; Sildenafil Citrate; Sulfones | 2010 |
6 other study(ies) available for lactic acid and sildenafil citrate
Article | Year |
---|---|
Severe hypoglycemia associated with an illegal sexual enhancement product adulterated with glibenclamide: MR imaging findings.
Topics: Adult; Aged; Blood Volume; Brain; Cerebrovascular Disorders; Coma; Consciousness Disorders; Diffusion Magnetic Resonance Imaging; Dominance, Cerebral; Drug Contamination; Glasgow Coma Scale; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Illicit Drugs; Image Processing, Computer-Assisted; Lactic Acid; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phytotherapy; Piperazines; Purines; Retrospective Studies; Seizures; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2009 |
Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Topics: Administration, Inhalation; Aerosols; Antihypertensive Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Excipients; Hypertension, Pulmonary; Kinetics; Lactic Acid; Nanoparticles; Nanotechnology; Nebulizers and Vaporizers; Particle Size; Phosphodiesterase 5 Inhibitors; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Purines; Sildenafil Citrate; Solubility; Solvents; Spectrophotometry, Ultraviolet; Sulfones; Technology, Pharmaceutical; Vasodilator Agents; Viscosity | 2012 |
Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.
Topics: Desiccation; Drug Carriers; Drug Compounding; Lactic Acid; Lung; Microscopy, Confocal; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Phosphodiesterase 5 Inhibitors; Piperazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Purines; Sildenafil Citrate; Sulfones | 2012 |
Isolated lung model for assessing drug absorption from PLGA microparticles.
Topics: Animals; Delayed-Action Preparations; Drug Liberation; Dry Powder Inhalers; Humans; Lactic Acid; Lung; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Sildenafil Citrate; Transition Temperature; Vasodilator Agents | 2016 |
Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
Topics: Administration, Inhalation; Administration, Oral; Animals; Drug Carriers; Humans; Hypertension, Pulmonary; Lactic Acid; Macrophages, Alveolar; Male; Microspheres; Muscle, Smooth, Vascular; Particle Size; Phosphodiesterase 5 Inhibitors; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pulmonary Artery; Rats, Sprague-Dawley; Sildenafil Citrate; Surface Properties; Vasodilator Agents | 2017 |
Lactic acid inhibits iNKT cell functions via a phosphodiesterase-5 dependent pathway.
Topics: Animals; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 5; Cytokines; Interferon-gamma; Lactic Acid; Mice; Mice, Inbred C57BL; Natural Killer T-Cells; Neoplasms; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil | 2021 |